Platform components considered an asset. Experience with administering and supporting SQL Server based enterprise applications... of and demonstrated ability to work with HTML, CSS, JavaScript, Python, TSQL, Dexterity, Batch, Powershell, VBA, SQL Server Reporting...
and troubleshoot complex SQL queries to extract, transform, and load data efficiently. Ensure data quality and integrity through... in Google Cloud Platform (GCP). Expertise in writing complex SQL queries and troubleshooting data pipelines. Knowledge...
the completion of ad-hoc analyses. Build and enhance reporting datasets using SQL, and automate refreshes of these... from complex data analysis Strong in SQL programing with minimum 1 year practical experience Proficient in understanding...
Overview: Are you a skilled SQL Database Administrator (DBA) eager to take on new challenges? Adastra..., improving, and maintaining new and existing databases Qualifications, Skills & Experience: Excellent knowledge of MS SQL...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »